基于纳米滚环扩增协同表面增强拉曼光谱法检测lncRNA用于急性肾损伤精准诊断
批准号:
22064009
项目类别:
地区科学基金项目
资助金额:
40.0 万元
负责人:
程子译
依托单位:
学科分类:
生命与公共安全分析
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
程子译
中文摘要
长链非编码核糖核酸(lncRNA)作为疾病的关键调控因子,在急性肾损伤生理病理过程中起重要作用。本项目拟结合表面增强拉曼光谱与超支化滚环扩增技术,合成多种结构的高灵敏拉曼探针,同时针对不同靶序列设计特异性挂锁探针,借助一体化微流控分析平台,在芯片内实现超支化滚环扩增与拉曼检测。通过扩增产物促进SERS探针形成纳米团簇,协同拉曼信号进行放大,从而实现低扩增数下的有效检测。构建预临床肾损伤模型用于相关lncRNA的检测,确定最优的探针与芯片设计,在组织、体液多层面上跟踪lncRNA变化,验证相关lncRNA在急性肾损伤精准诊断中的作用,同时深入探究该检测手段的临床适用性。在检测时间、可重复性、稳定性与灵敏度上实现突破,提高实际检测中急性肾损伤诊断结果的准确性。研究结果预期为临床急性肾损伤的检测提供快速高灵敏的液体活检新方法,进而为急性肾损伤的早期精准诊断、术中以及预后的监测提供数据支撑。
英文摘要
Considerable interest has been aroused in long non-coding RNA (lncRNA) due to its vital roles in various pathophysiological processes of acute kidney injury (AKI). This project intends to combine surface-enhanced Raman spectroscopy and hyper-branched rolling circle amplification, to synthesize highly sensitive Raman probes of various structures, and to design specific padlock probes for the detention of different target sequences. Highly sensitive detection of target lncRNA will be performed by hyperbranched rolling circle amplification and Raman detection in the integrated microfluidic analysis platform. The amplification product promotes the formation of nanoclusters. Thus amplifying the Raman signal, and achieving effective detection at low amplification numbers. A pre-clinical kidney injury model will be designed for the detection of the AKI related lncRNA. By optimizing SERS probes, chip design and tracking related lncRNA changes on tissues and body fluids, This will help for further understanding related lncRNA in the accurate diagnosis of acute kidney injury and stretch out the in-depth clinical capability of the proposed method. A breakthrough will be achieved in detection time, repeatability, stability, and sensitivity to improve the accuracy of the AKI diagnosis in practical detection. The results are expected to establish a new method of rapid and highly sensitive lncRNA humoral biopsy in complex environments, hoping to provide a research basis for early accurate diagnosis of clinical acute kidney injury, timely feedback of intraoperative data and effective postoperative monitoring.
本项目围绕疾病精准诊断难题,创新性地构建了基于纳米滚环扩增协同表面增强拉曼光谱(SERS)的精准分析体系,并结合微流控技术,实现了高灵敏、高特异、高通量的检测目标。本项目开发了一种磁珠-滚环扩增-金纳米粒子(MB-RCA-AuNPs)复合SERS生物传感平台,优化Padlock探针设计,实现了单核苷酸变异(SNV)高特异性识别。基于滚环扩增的超长单链DNA结构和等离子体耦合效应,显著增强了拉曼信号,实现飞摩尔(fM)级别的超低浓度检测,同时表现出良好的重现性(批间RSD<7%)。项目团队进一步构建了微流控芯片检测平台,通过液滴微流控技术实现单次检测数千个独立反应液滴,大幅提升检测通量和效率。该平台优化了样品处理-分子识别-信号放大-检测分析的自动化流程,单次检测时间缩短至30分钟,并在低样本量条件下实现了高灵敏、高特异的检测。临床样本验证结果表明,该方法灵敏度和特异性分别达到80.0%和83.3%,较传统RT-PCR方法更具优势,为快速筛查和精准诊断提供了新技术。此外,团队开发了SERS-RCA-微流控即时检测(POCT)平台,用于miRNA超灵敏检测,检测限达到0.29 fM(miRNA-21)和0.37 fM(miRNA-155),在检测时间、稳定性和可重复性方面均表现优异。同时,研究团队进一步开发了Y型Aptasensor SERS生物传感器,用于AKI相关蛋白标志物NGAL和Cys C的双重检测,检测限分别达到0.052 ng/mL和0.34 ng/mL,为临床分子诊断提供了新的检测手段。本研究成果在疾病标志物高灵敏检测领域具有重要的应用价值。研究团队已在Advanced Functional Materials, Chemical Engineering Journal, Advanced Healthcare Materials, ACS Sensors, Analytical Chemistry等高水平期刊共发表SCI论文10篇,申请国家发明专利4项,授权国家发明专利2项,国际发明专利1项,培养硕/博士研究生5人,较好地完成了预期研究目标,并为临床AKI精准诊断及分子生物传感技术的发展提供了理论与技术支撑。
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:--
-
项目类别:省市级项目
-
资助金额:0.0万元
-
批准年份:2026
-
负责人:程子译
-
依托单位:
国内基金
海外基金